The Hormone Replacement Therapy Market is estimated to be valued at US$ 14288.76 Mn in 2023 and is expected to exhibit a CAGR of 5.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview: Hormone replacement therapy is used to treat patients suffering from hypoestrogenism or lack of natural estrogen production in the body. It is used for the treatment of menopausal symptoms or osteoporosis in postmenopausal women. The treatment provides the hormone balance, maintains bone density and prevents early menopause induced chronic diseases. Market key trends: One of the major trends fueling the growth of the hormone replacement therapy market is increasing geriatric population. According to the United Nations Population Fund (UNFPA) report, the number of people over 60 years will nearly double from 12% to 22% of world’s population between 2015 and 2050. The geriatric population is more prone to hormonal deficiencies. For instance, postmenopausal women are likely to suffer lack of estrogen due to termination of periods. This has resulted in the growing demand for hormone replacement therapy. In addition, growth of healthcare facilities, rising awareness about menopausal healthcare management, and increasing strategic developments by key players are some other major factors expected to boost the market growth over the forecast period. Porter’s Analysis Threat of new entrants: The threat of new entrants is moderate as the Hormone Replacement Therapy market requires high capital investment and years of research. However, new startups with innovative therapies can pose a threat. Bargaining power of buyers: The bargaining power of buyers is high as there are many substitutes available in the market. Buyers can switch to alternative therapies easily. Bargaining power of suppliers: The bargaining power of suppliers is moderate as suppliers have to rely on a few large players for sales in this consolidating market. Threat of new substitutes: The threat of new substitutes is high as researchers are constantly developing novel therapies for menopause like alternative herbal supplements. Competitive rivalry: Intense competition among existing players. SWOT Analysis Strength: Wide range of products available, Large customer base due to growing aging population, Strong brand image and recognition among patients. Weakness: High R&D and marketing costs, Supply chain and manufacturing complexities, Risk of side-effects and complications. Opportunity: Emerging markets offer high growth potential, Personalized hormone therapy can boost demand, Use of combination therapies can increase treatment effectiveness. Threats: Patent expirations increase generic competition, Stringent regulatory approvals delay product launches, Social stigma and risk aversion reduces patient acceptance. Key Takeaways The Global Hormone Replacement Therapy Market Size is expected to witness high growth, exhibiting CAGR of 5.4% over the forecast period, due to increasing prevalence of hormonal imbalance disorders among aging population globally. The United States holds the largest share in the HRT market owing to the presence of major players and developed healthcare infrastructure. However, Asia Pacific region is anticipated to grow at the fastest pace during 2023-2030 period driven by rising healthcare expenditure, increasing disposable incomes and growing medical tourism in countries like India, China and South Korea. Key players operating in the Hormone Replacement Therapy market are Novartis AG, Abbott Laboratories, Mylan N.V., Merck KgaA, Bayer AG, Pfizer Inc., Novo Nordisk A/S, QuatRx Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Amgen, Inc., and Eli Lilly and Company. Major players are focusing on expanding their product portfolios through acquisitions and new product launches. Read more: https://www.rapidwebwire.com/hormone-replacement-therapy-market-size-forecast/
0 Comments
|
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |